CHINA PHARMA HLDGS INC - COM (CPHI)

CUSIP: 16941T104

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
449,773
Share change
+69,845
Total reported value
$109,000
Price per share
$0.24
Number of holders
6
Value change
+$18,202
Number of buys
4
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 16941T104?
CUSIP 16941T104 identifies CPHI - CHINA PHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHINA PHARMA HLDGS INC - COM (CPHI) as of Q2 2016

As of 30 Jun 2016, CHINA PHARMA HLDGS INC - COM (CPHI) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 449,773 shares. The largest 6 holders included GLENHILL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, KCG Holdings, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GOLDMAN SACHS GROUP INC. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.